๐ค AI Summary
This study addresses the limitation of existing medical digital twins, which are typically static or passively updated and thus unable to synchronize in real time with the dynamic evolution of phenotypic and genomic knowledge in rare genetic diseases. To overcome this, the work introduces autonomous agent orchestration into the domain for the first time, leveraging the OpenClaw framework to develop a digital twin system equipped with an โactive heartbeatโ mechanism. This system employs modular agent skills to automatically ingest, standardize, and integrate multisource data, enabling continuous, auditable synchronization between patient models and the latest clinical and genomic knowledge. A prototype implementation successfully supported longitudinal phenotypic tracking and variant reinterpretation in two case studies, significantly enhancing early diagnostic accuracy and disease progression modeling for rare disorders.
๐ Abstract
Background: Medical Digital Twins (MDTs) are computational representations of individual patients that integrate clinical, genomic, and physiological data to support diagnosis, treatment planning, and outcome prediction. However, most MDTs remain static or passively updated, creating a critical synchronization gap, especially in rare genetic disorders where phenotypes, genomic interpretations, and care guidelines evolve over time.
Methods: We propose an agent-orchestrated digital twin framework using OpenClaw's proactive "heartbeat" mechanism and modular Agent Skills. This Autonomous Agent-orchestrated Digital Twin (AADT) system continuously monitors local and external data streams (e.g., patient-reported phenotypes and updates in variant classification databases) and executes automated workflows for data ingestion, normalization, state updates, and trigger-based analysis.
Results: A prototype implementation demonstrates that agent orchestration can continuously synchronize MDT states with both longitudinal phenotype updates and evolving genomic knowledge. In rare disease settings, this enables earlier diagnosis and more accurate modeling of disease progression. We present two case studies, including variant reinterpretation and longitudinal phenotype tracking, highlighting how AADTs support timely, auditable updates for both research and clinical care.
Conclusion: The AADT framework addresses the key bottleneck of real-time synchronization in MDTs, enabling scalable and continuously updated patient models. We also discuss data security considerations and mitigation strategies through human-in-the-loop system design.